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Edited by David LambethAbstract We used animal models to study connection between
oxidating system and sphingomyelin signaling cascade, because
this models are more close related to people disease. Activation
of n-sphingomyelinase (n-SMase) in mice liver and brain is
coincided in time with increased level of peroxide products
(conjugated dienes) after injection of tumor necrosis factor a
(TNF-a). We found that ceramide can induce peroxide oxidation
and lead to accumulation of TNF-a in animal organs. Nitric
oxide (NO) donors (S-nitrosoglutathione and dinitrosyl iron
complex) reversibly inhibited activity of n-SMase and decreased
level of lipid peroxidation products. This data proposed that both
SMase and messengers of oxidative systems could be targets for
NO-derived oxidants.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Oxidative stress has traditionally been viewed as a stochastic
process of cell damage resulting from aerobic metabolism, and
antioxidants have been viewed simply as free radical scaveng-
ers. Only recently has it been recognized that reactive oxygen
species (ROS) are widely used as second messengers to propa-
gate proinﬂammatory, growthstimulatory and apoptotic sig-
nals. Several protein kinase cascades and transcription
factors can be activated not only by receptor-targeted ligands
[1,2] but also by direct application of oxidazing agents , partic-
ularly H2O2 [3] or ionizing radiation [4]. H2O2 may be synthe-
sized endogenously in certain cell types as a response to
activation by speciﬁc cytokines [5] or growth factors [6].
ROS have been involved in the induction of apoptosis [7,8].
Several observations support this hypothesis.Abbreviations: DNIC, dinitrosyl iron complex; GSH, glutathione;
GSNO, S-nitrosoglutathione; LPO, lipid peroxidation; NO, nitric
oxide; n-SMase, n-sphingomyelinase; ROS, reactive oxygen species;
SM, sphingomyelin; TNF-a, tumor necrosis factor a
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hydrogen peroxide (H2O2) or lipid peroxides can trigger
apoptosis [9,10].
2. Various cellular antioxidants are able to block apoptosis
[11,12].
3. Broad-spectrum antiapoptotic proteins like the protoonco-
gene Bcl-2 and the baculovirus protein p35 have been de-
scribed as antioxidants [13].
Several mechanisms for induction of apoptosis by ROS have
been proposed, but integral model is not established. A grow-
ing body of evidence is slowly emerging indicating that oxida-
tive stress and activation of sphingomyelin (SM) pathway are
intimately connected in cell cycle and apoptotic signaling.
The SM pathway has been recognized as a ubiquitous signal-
ing system that links speciﬁc cell-surface receptors and envi-
ronmental stresses to the nucleus [14]. This pathway is
initiated by the hydrolysis of SM via the action of SMases to
generate ceramide [14,15]. Ceramide then serves as a second
messenger in this system, leading to apoptosis [15]. Biochemi-
cal analysis of recombinant and partially puriﬁed mouse n-
SMase showed that the enzyme has reactive cysteine residues
and that its enzymatic activity is redox-regulated [16]. Indeed,
sphingomyelinase (n-SMase) is reversibly activated by H2O2
[17,18] and reversibly inhibited by glutathione (GSH) [19–
21]. It means that cross-talk between oxidation system and
SM cycle exists in living cells and could have important impli-
cation for developing apoptosis which plays important role in
many kinds of diseases.
In our experiments we used animal models to study connec-
tion between oxidation system and SM signaling cascade, be-
cause this models are more complicated than cell models and
more close related to people disease.2. Materials and methods
2.1. Materials
[14C-methyl] SM was supplied by Amersham Pharmacia. Anti
tumor necrosis factor a (TNF-a) antibody was from Santa Cruz. Recom-
binant TNF-a was generous gift from Dr. V.G. Korobko (Shemyakin-
Ovchinnikov Institute of Bioorganic Chemistry, RAS), ceramide from
bovine brain was purchased from Sigma. Nitric oxide (NO)-releasing
compounds – S-nitrosoglutathione (GSNO), and all other chemicals
were obtained from Sigma. Dinitrosyl iron complexes (DNIC) with
GSH were obtained by treatment of 5.4 mM FeSO4 and 10.8 mM
GSH (iron/GSH = 1:2 w/w) with gaseous NO in a Thunberg vessel un-
der 200–300 mm Hg pressure in 15 mM HEPES buﬀer (pH 7.4), under
vacuum.ation of European Biochemical Societies.
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method by intensity of EPR signal from the complex and performing
double integration.
Male Balb mice weighing 18–20 g were used in our experiment in
accordance with the European Communities Council Directive (86/
609/EEC) for the care and use of animals for experimental procedure.
TNF-a, NO-donors (GSNO and DNIC) and 1% alcohol solution of
ceramide were injected to mice intraperitoneally. Ceramide for injec-
tion to animals was prepared as a 10· solution in 10% ethanol in
0.5 m NaCl by sonication twice for 1 min at room temperature.
For each experimental point we used three animals.
2.2. Measurement of neutral SMase activity
Fresh brain and liver were washed with Hanks buﬀer and then
homogenized in neutral SMase assay.
The activity of SMase from mice liver and brain was measured using
radiolabelled substrate [14C-methyl] SM as previously described [21].
Brieﬂy, liver and brain homogenates were incubated with [14C-methyl]
SM for 1 h at 37 C. Following quenching and phase separation, a
sample of the aqueous phase was analyzed by scintillation counting.
2.3. Protein determination, SDS–PAGE and Western blotting
Protein concentrations were determined according Lowrys method
[22]. Samples for gel electrophoresis were combined with nonreducing
4· SDS sample buﬀer and separated by SDS–PAGE. Gels were
stained by Coomassie brilliant blue R-250. For Western blotting, fol-
lowing separation by SDS–PAGE, proteins were electro-transferred
to polyvinylidene diﬂuoride membrane. The membrane was blocked
with Tris-buﬀered saline/Tween 20 (TBS) containing 5% dried milk
powder for 1 h. Anti-poly TNF-a (1:1000) was added for 1 h in
TBS followed by washing. Secondary antibody was added for
30 min. Following washing, ECL (Amersham Pharmacia Biotech)
was used for detection.
Values of TNF-a we obtained using scanning densitometry. Cali-
brated curves obtained with recombinant TNF-a were used for moni-
toring of TNF-a quantity by densitometry after all Western-blot
procedures.
2.4. Lipid extraction and determination of SM and ceramide
Lipids from brain and liver were extracted according to Bligh and
Dyer [23]. SM and ceramides were separated by HPTLC.
2.5. Detection of lipid peroxide products in lipids from mice liver and
brain
Lipid peroxidation (LPO) intensity were measured spectrophoto-
metricaly as conjugated dienes and ketodienes content (at 233 and
270 nm, respectively) in lipid extracts.
Calculations and statistics. All values are presented as mean-
s ± S.E.M. and represent a minimum of two independent experiments
of triplicate samples. Statistical comparisons were performed by Stu-
dents t test.Fig. 1. Changes in neutral SMase activity and ceramide content in
brain and liver after TNF-a administration in dose of 100 lg per
mouse. 1, SMase activity in brain; 2, SMase activity in liver; 3,
ceramide content in brain; 4, ceramide content in liver. Data shown are
representative of two separate experiments of triplicate samples with
similar results. Results are shown as means ± S.E.M.; * signiﬁcant
diﬀerence from control (P < 0.05, Students t test).3. Results and discussion
3.1. Inﬂuence of TNF-a on SM cycle and lipid peroxide
oxidation in mice liver and brain
The most experiments with many of chemical and physical
treatments capable of inducing apoptosis, generating oxidative
stress and activating SM–ceramide pathway have been done at
the cell models [24–26]. Inﬂammatory cytokines such as TNF-
a have been reported to generate ROS in various cells and are
also well-known inducers of ceramide formation in several cell
types. Pharmacological inhibition of the rise in ROS level fol-
lowing ligand treatment was shown to prevent activation of the
SM–ceramide pathway [27,28].
In our case recombinant TNF-a was injected to animals in
doses 100 lg per mouse. Changes in SMase activity and level
of ceramides in liver and brain are presented on Fig. 1 Activa-tion of SMase in brain was found after 15–30 min and between
1.5 and 2.5 h (Fig. 1, line 1). Increased activity of enzyme in
liver was detected within 1.5–3 h, but it was decreased at 5 h
after injection (Fig. 1, line 2). It can be connected with activa-
tion of iNO-synthase and accumulation of NO in liver cells in-
duced by TNF-a. Our previous data showed that
administration of bacterial lipopolysaccharide-inducer of
TNF-a stimulated NO formation in mouse liver within 3.5–
4 h and kept increased level of NO between 3.5 and 9.5 h
[29]. Later we showed that releasing of NO decreased activity
of n-SMase in mouse liver (see Fig. 5).
Level of ceramides in brain and liver is increased after acti-
vation of SMase (Fig. 1) Determination of lipid peroxide acti-
vation showed increased level of peroxide products (ketodienes
and conjugated dienes) after 30 min TNF injection both in
brain and liver and after 2 h in liver (Fig. 2).
TNF-a has been shown to play an important role in the
pathogenesis of number of CNS and liver diseases such as mul-
tiple sclerosis, AIDS dementia and Alzheimers disease [30],
ischemia of liver [31], acute and chronic viral hepatitis, chole-
stasis, etc. [32]. Receptors for TNF-a are located on the surface
of both nerve and liver cells. Although TNF-a is produced by
the brain and liver Kupﬀers cells, many eﬀects on the CNS
have been found to occur after its injection into the blood or
intraperitoneally. It has been stated that TNF-a is able to cross
the blood–brain barrier by a saturable transport system [33].
Thus our results indicate that TNF-a induces SMase pathway
and activates oxidative stress in vivo the same manner as
in vitro.
3.2. Eﬀect of ceramide on lipid oxidation and TNF-a expression
in mice liver and brain
It was shown that in living cells ceramide-generating enzyme
is regulated by the intracellular redox state including GSH and
bilirubin [19–21,34]. In our previous experiments we showed
that injection GSH to mice in doses 18 mg per mouse [21]
Fig. 3. Changes in lipid peroxide products in brain and liver after
administration of ceramide in doses of 100 lg per mouse. 1, conjugated
dienes in brain; 2, ketodienes in brain; 3, conjugated dienes in liver; 4,
ketodienes in liver. Data shown are representative of two separate
experiments of triplicate samples with similar results. Results are
shown as means ± S.E.M.
Fig. 4. Changes in TNF-a level in brain (1) and liver (2) after
administration of ceramide in doses of 100 lg per mouse. Data shown
are representative of two separate experiments of triplicate samples
with similar results. Results are shown as means ± S.E.M.
Fig. 2. Changes in LPO products content in liver and brain after TNF-
a administration in dose of 100 lg per mouse. 1, conjugated dienes in
brain; 2, ketodienes in brain; 3, conjugated dienes in liver; 4, ketodienes
in liver. Data shown are representative of two separate experiments of
triplicate samples with similar results. Results are shown as means
± S.E.M.
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of n-SMase in animal organs. Our data obtained with animals
support previous data described by Hannun and other authors
in vitro [19,20]. There are many indications that GSH inﬂu-
ences the SMase–ceramide pathway in apoptotic process. We
also showed that GSH and bilirubin inhibit apoptosis in iso-
lated thymocites treated by sphingosine and UV-irradiation
[34].
While manipulation with nonenzymatic antioxidant system
aﬀect ceramide production, formation of this sphingolipid
can also modulate oxidative stress. Exposure of cultured rat
hepatocytes to exogenous bacterial SMase resulted in ROS for-
mation [35].
We also demonstrated that injection of ceramide in doses
of 100 lg per mouse induces accumulation of the level of
peroxide lipid products in liver and brain cells between 5
and 20 h after injection (Fig. 3). We tested the elevation
of ceramide in liver and brain after its administration be-
tween 30 min and 2 h (data are not presented). Moreover
we showed that injection of ceramide induced accumulation
of TNF-a in liver and brain within 2–15 h (Fig. 4). Then
level of TNF-a decreased to control data after 24 h.
It means that generation of SM product by exogenous
TNF-a can induce endogenous accumulation of TNF-a
which in its turn generates new portion of ceramide. By this
results we can explain biphase accumulation of ceramide in
cells treated by TNF-a [36].
3.3. NO-generated products inhibit activity of SMase and lipid
peroxide oxidation in mice liver
NO and NO-derived oxidant are important messengers
that play role in physiological and pathological processes
such as apoptosis, vasorelaxation and inﬂammation [37,38].
It is now established that ceramide generation is regulated
either positively or negatively by NO and NO reactive spe-
cies [39]. These data suggested that SMase could be target
of NO-derived oxidants. NO and SM cycle signaling path-
ways and lipid oxidation reactions are of central importancein apoptotic and/or necrotic cell death. Since NO signaling
pathway and LPO involve free radical species that can also
react together at extremely fast rates and the activity of
SMase – the key enzyme of SM cycle correlates with the le-
vel of oxidizing lipids, convergent interaction between these
pathways are expected. Proposing a link between NO gener-
ation, activation of SM cycle and accumulation of lipid per-
oxide products we investigated interfering biochemical
signaling pathways. Therefore, we tested the ability of NO-
releasing compounds GSNO and dinitrosyl iron complex
(DNIC) to change the activity of SMase and level of conju-
gated dienes after their injection to mice. GSNO was in-
jected in doses 3 mg per mouse, DNIC in doses – 1.5 mg
per mouse. All NO donors caused changes in the activity
Fig. 5. Changes in SMase activity and ceramide level in liver after
administration of NO donors – DNIC in dose of 1.5 mg per mouse and
GSNO in dose of 3 mg per mouse. 1, SMase activity after DNIC
administration; 2, SMase activity after GSNO administration; 3,
ceramide level after DNIC administration; 4, ceramide level after
GSNO administration. Data shown are representative of two separate
experiments of triplicate samples with similar results. Results are
shown as means ± S.E.M.
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dent manner. We found that the activity of SMase and level
of ceramide are changed during 4 h after administration of
NO donors by a dual mechanism (Fig. 5).
On the one hand NO inhibits the SM-metabolizing enzyme
(neutral SMase) and ceramide formation during 15–30 min,
and on the other hand it normalizes activity of enzyme and cer-
amide level after 4 h GSNO and DNICs actions. SMase activ-
ity coincided in time with level of LPO products (decreased
level of conjugated dienes within 15–30 min ) after injection
of GSNO and DNIC (Fig. 6). It was shown previously thatFig. 6. Changes in lipid peroxide products in liver after administration
of DNIC in dose of 1,5 mg per mouse and GSNO in dose of 3 mg per
mouse. 1, conjugated dienes after administration of DNIC; 2,
conjugated dienes after administration of GSNO; 3, ketodienes after
administration of DNIC; 4, ketodienes after administration of GSNO.
Data shown are representative of two separate experiments of
triplicate samples with similar results. Results are shown as means
± S.E.M.NO can inhibit or activate oxidation reaction depending on
its level in cells [40]. NO can reduce lipid oxygen species
according to the reactions [41]:
LO þ NO! LONO
LOO þ NO! LOONO
Probably in our case we registered this type of reaction, but
NO can not oxidize lipids directly, only its oxidized products
(peroxynitrite or N2O) very rapidly increase lipid oxygen spe-
cies.
O2 ! ONOO ! LO
NO Lipids
So inhibition of SMase in liver cells by NO donors has been
shown to be reversible. These data suggested that n-SMase
could be inhibited by NO or peroxynitrite, which is the prod-
uct of reaction of NO with superoxide [42]. In vivo peroxyni-
trite formation has been described during sepsis,
autoimmune and inﬂammatory conditions [43]. Peroxynitrite
is one of the most reactive NO-derived oxidants implicated
in oxidative modiﬁcation of proteins [44]. In our case it is quite
possible that peroxynitrite is responsible for inhibition of n-
SMase. The interaction of NO and NO reactive species with
reactive cysteine-containing proteins has gained considerable
importance [45]. As it was mentioned early SMase has reactive
cystein residues [16] which can be inactivated by NO reactive
species. It is become more clear because level of lipid peroxide
products in liver is decreased and they can not inﬂuence on the
inhibition of SMase.
Although the above sets of observation link SM pathway
and oxidative stress in cell death, relatively little is known
regarding speciﬁc mechanisms through which oxidative stress
acts on sphingolipid signaling. One could speculate that ROS
have direct protein targets. Whether this protein is SMase or
a protein with phospholipase, protein kinase, or protease
activity, which in turn regulate SMase, still remains un-
known.
Many of the relationship between oxidative stress and
SM-signaling remain still obscure. It will be of special inter-
est to determine the exact molecular mechanism and the
subcellular localization of these interaction. This will allow
a better to understand the roles of ROS and ceramide
production as mediators of cell death and of their functions
in the pathophysiology of various diseases implicating apop-
tosis.
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